SurgiMend PRS Meshed, Revize-X

Mesh, Surgical, Collagen, Plastic And Reconstructive Surgery

Integra LifeSciences Corporation (Owner Of TEI Biosciences)

The following data is part of a premarket notification filed by Integra Lifesciences Corporation (owner Of Tei Biosciences) with the FDA for Surgimend Prs Meshed, Revize-x.

Pre-market Notification Details

Device IDK171357
510k NumberK171357
Device Name:SurgiMend PRS Meshed, Revize-X
ClassificationMesh, Surgical, Collagen, Plastic And Reconstructive Surgery
Applicant Integra LifeSciences Corporation (Owner Of TEI Biosciences) 7 Elkins Street Boston,  MA  02127
ContactKavita Amin
CorrespondentKavita Amin
Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro,  NJ  08536
Product CodeOXH  
CFR Regulation Number878.3300 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2017-05-09
Decision Date2017-06-07
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
10381780357322 K171357 000
10381780357315 K171357 000
10381780357308 K171357 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.